A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen

Journal of Virological Methods

Volumn 157, Issue 1, 2009, Pages 8-14

  Morota, Kaori ^a   Fujinami, Ryo ^a   Kinukawa, Hideki ^a   Machida, Taiji ^b   Ohno, Kenichi ^b   Saegusa, Haruhisa ^b   Takeda, Katsumichi ^a  

^a Abbott Japan Co Ltd   (Japan)

^b DENKA COMPANY LIMITED   (Japan)

Author keywords

Chemiluminescent immunoassay; HCV core antigen; Hepatitis C

Indexed keywords

VIRUS ANTIGEN; VIRUS RNA;

ARTICLE; AUTOANALYSIS; BLOOD DONOR; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION COEFFICIENT; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNORADIOMETRIC ASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROPARTICLE ENZYME IMMUNOASSAY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; VIRUS CORE; VIRUS DETECTION;

ANTIGENS, VIRAL; AUTOMATION; CHEMILUMINESCENT MEASUREMENTS; HEPACIVIRUS; HUMANS; IMMUNOASSAY; MICROSPHERES; PLASMA; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SERUM; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 60849089607     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.12.009     Document Type: Article

References (23)

1. Aoyagi K., Ohue C., Iida K., Kimura T., Tanaka E., Kiyosawa K., and Yagi S. Development of a simple and highly sensitive enzyme immunoassay for Hepatitis C virus core antigen. J. Clin. Microbiol. 37 (1999) 1802-1808
2. Bouvier-Alias M., Patel K., Dahari H., Beaucourt S., Larderie P., Blatt L., Hezode C., Picchio G., Dhumeaux D., Neumann A.U., McHutchison J.G., and Pawlotsky J.M. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 36 (2002) 211-218
3. Enomoto M., Nishiguchi S., Tamori A., Kohmoto M., Habu D., Sakaguchi H., Takeda T., Kawada N., Seki S., and Shiomi S. Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon-α2b and Ribavirin therapy in patients with genotype 1 and high viral loads. J. Med. Virol. 77 (2005) 77-82
4. Fabrizi F., Lunghi G., Aucella F., Mangano S., Barbisoni F., Bisegna S., Vigilante D., Limido A., and Martin P. Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients. J. Clin. Microbiol. 43 (2005) 414-420
5. Glynn S.A., Wright D.J., Kleinman S.H., Hirschkorn D., Tu Y., Heldebrant C., Smith R., Giachetti C., Gallarda J., and Busch M.P. Dynamics of viremia in early hepatitis C virus infection. Transfusion 45 (2005) 994-1002
6. Gonzalez V., Padilla E., Diago M., Gimenez M.D., Sola R., Matas L., Montoliu S., Morillas R.M., Perez C., and Planas R. Clinical usefulness of total hepatitis C virus core antigen quantification to monitor the response to treatment with peginterferon alpha-2a plus Ribavirin. J. Viral Hepat. 12 (2005) 481-487
7. Gretch D.R., Corey L., de la Rosa C., and Carithers R.L. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann. Intern. Med. 123 (1995) 321-329
8. Hayashi K., Hasuike S., Kusumoto K., Ido A., Uto H., Kenji N., and Kohara M. Usefulness of a new immuno-radiometric assay to detect hepatitis C core antigen in a community-based population. J. Viral Hepat. 12 (2005) 106-110
9. Higuchi M., Tanaka E., and Kiyosawa K. Epidemiology and clinical aspects on hepatitis C. Jpn. J. Infect. Dis. 55 (2002) 69-77
10. Maynard M., Pradat P., Berthillon P., Picchio G., Voirin N., Martinot M., Marcellin P., and Trepo C. Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy. J. Viral Hepat. 10 (2003) 318-323
11. NCCLS, 2004. Evaluation of Precision Performance of Quantitative Measurement Methods. Approved Guideline-Second Edition. NCCLS document EP5-A2. NCCLS, Wayne, PA.
12. Niederau C., Lange S., Heintges T., Erhardt A., Buschkamp M., Hürter D., Nawrocki M., Kruska L., Hensel F., Petry W., and Häussinger D. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 28 (1998) 1687-1695
13. Pawlotsky J.M. Diagnostic tests for hepatitis C. J. Hepatol. 31 (1999) 71-79
14. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium, 1999. Global surveillance and control of hepatitis C. J. Viral Hepat. 6, 35-47.
15. Richter S.S. Laboratory assays for diagnosis and management of hepatitis C virus infection. J. Clin. Microbiol. 40 (2002) 4407-4412
16. Saito R., Yokota H., Takahashi E., Mashige F., Yoneyama A., Nakahara K., and Okamura N. Performance of an automated system for quantitation of hepatitis C virus core antigen. J. Virol. Methods 112 (2003) 93-97
17. Simmonds P. Genetic diversity and evolution of hepatitis C virus-15 years on. J. Gen. Virol. 85 (2004) 3173-3188
18. Simmonds P., Bukh J., Combet C., Deléage G., Enomoto N., Feinstone S., Halfon P., Inchauspé G., Kuiken C., Maertens G., Mizokami M., Murphy D.G., Okamoto H., Pawlotsky J.M., Penin F., Sablon E., Shin-I T., Stuyver L.J., Thiel H.J., Viazov S., Weiner A.J., and Widell A. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42 (2005) 962-973
19. Takahashi K., Okamoto H., Kishimoto S., Munekata E., Tachibana K., Akahane Y., Yoshizawa H., and Mishiro S. Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts. J. Gen. Virol. 73 (1992) 667-672
20. Takahashi M., Saito H., Higashimoto M., Atsukawa K., and Ishii H. Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy. J. Clin. Microbiol. 43 (2005) 186-191
21. Tanaka E., Ohue C., Aoyagi K., Yamaguchi K., Yagi S., Kiyosawa K., and Alter H.J. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology 32 (2000) 388-393
22. Veillon P., Payan C., Picchio G., Maniez-Montreuil M., Guntz P., and Lunel F. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA and Amplicor Monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus Ribavirin combination therapy. J. Clin. Microbiol. 41 (2003) 3212-3220
23. Zanetti A.R., Romano L., Brunetto M., Colombo M., Bellati G., and Tackney C. Total HCV core antigen assays: a new marker of hepatitis C viremia for monitoring the progress of therapy. J. Med. Virol. 70 (2003) 27-30